CDC advisory panel votes to push measles vaccine recommendation to 4-years-old
The ACIP is expected to vote on several key recommendations during two-days of meetings this week, including recommendations regarding the COVID-19 vaccination, which will be debated on Friday.
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted Thursday to recommend that the combined measles, mumps, rubella and varicella (MMRV) vaccine not be given to children under the age of four-years-old.
The ACIP is expected to vote on several key recommendations during two-days of meetings this week that began Thursday, including recommendations regarding the COVID-19 vaccination, which will be debated on Friday.
The committee's decisions could set out a new path for the country's vaccination policy, particularly for the country's childhood immunization schedules.
The panel voted 8-3 to recommend the MMRV vaccine to children over the age of four. Children can currently get the vaccine as young as 12-months, according to The Hill.
The controversy around the MMRV vaccine is that children under the age of four face a slightly increased risk of having a febrile seizure when getting the injection, even though the seizures do not usually have long-lasting effects.
ACIP Chairman Martin Kulldorff warned that the seizures could scare parents into not getting their children the vaccine at all.
Misty Severi is a news reporter for Just The News. You can follow her on X for more coverage.